The antibody quantification market is projected to grow from USD 7.8 billion in 2026 to USD 17.0 billion by 2036, at a CAGR of 8.1%. Primary Antibodies will dominate with a 61.0% market share, while elisa & immunoassays will lead the assay type segment with a 50.0% share.